Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Investigating the role of poly(ADP-ribose) polymerase-1 in the response of human tumour cells to low doses of ionising radiation

A. Chalmers, M. Woodcock, P. Johnston

Med Sci Monit 2003; 9(1): 9-0 :: ID: 15055

Abstract

Background:The spectrum of DNA lesions induced by ionising radiation varies according to dose delivered; hence the relative importance of DNA repair proteins is also likely to vary with dose. Depletion or inhibition of PARP-1 is associated with radiosensitisation to doses of 2 Gy and above [1]; its activation by single strand breaks and interactions with the base excision repair pathway [2] suggest a potential role in the response to lower doses. Inhibition of PARP-1 may thus enhance the response of tumours to ultrafractionated and low dose rate radiotherapy protocols. We tested the effect of chemical inhibitors of PARP on low dose clonogenic survival in a range of hamster fibroblast and human tumour cell lines in PARP-1 knockout mouse embryo fibroblasts (MEF) [3]. Material/Methods: Clonogenic survival of T98G and U373 human glioma cells, V79 and CHO hamster fibroblasts, and 3T3 MEF PARP-1 knockout and control cells following low-dose irradiation in the presence of chemical PARP inhibitors was measured using a fluorescence-activated cell sorting assay [4].Results:Whilst PARP inhibition induced radiosensitisation of V79, CHO and T98G cells in the 0.05–0.5 Gy dose range, there was no such effect in the PARP-1 knockout cells compared with controls. Radiosensitisation to doses greater than 1.5 Gy occurred in all cell lines.Discussion:The discrepancy between the effect of chemical inhibition of PARP enzymes and deletion of the PARP-1 gene suggests that compensatory low dose repair mechanisms are upregulated in PARP-1 knockout cells, or that inhibition of both PARP-1 and PARP-2 is required for low dose radiosensitisation.References: 1.Shall S, de Murcia G: Mutation Research, 2000; 460: 1-15 2.Dantzer F, de la Rubia et al: Biochemistry, 2000; 39: 7559-69 3.de Murcia JM, Niedergang C et al: Proc Nat Acad Sci, 1997; 95: 7303-7 4.Skwarchuk MW, Wouters BG, Skarsgard LD: Int J Radiat Biol, 1993; 64: 601-12

Keywords: poly(ADP-ribose) polymerase-1, chemical inhibitors, low dose radiation

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750